1. Home
  2. BILL vs LGND Comparison

BILL vs LGND Comparison

Compare BILL & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BILL Holdings Inc.

BILL

BILL Holdings Inc.

HOLD

Current Price

$49.58

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$292.84

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BILL
LGND
Founded
2006
1987
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.7B
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
BILL
LGND
Price
$49.58
$292.84
Analyst Decision
Buy
Strong Buy
Analyst Count
21
7
Target Price
$57.90
$256.29
AVG Volume (30 Days)
2.4M
218.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
74.07
2886.36
EPS
0.07
1.63
Revenue
$1,462,570,000.00
$141,102,000.00
Revenue This Year
$14.18
$1.25
Revenue Next Year
$13.83
$19.41
P/E Ratio
$733.00
$177.19
Revenue Growth
13.36
29.48
52 Week Low
$31.41
$149.51
52 Week High
$57.21
$326.63

Technical Indicators

Market Signals
Indicator
BILL
LGND
Relative Strength Index (RSI) 62.32 50.08
Support Level $35.27 $286.99
Resistance Level $49.60 $322.06
Average True Range (ATR) 2.10 11.50
MACD 0.07 -1.54
Stochastic Oscillator 64.80 30.49

Price Performance

Historical Comparison
BILL
LGND

About BILL BILL Holdings Inc.

BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: